V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270014399 | 270014738 | null | 54.2 | Adjuvant (A) | 2014-01-21 | 2014-02-11 | AFLIBERCEPT + FU + IRINOTECAN | N | N | 270018269 | VINBLASTINE |
| 270014400 | 270017133 | 1.54 | null | Curative (C) | 2015-05-30 | 2015-05-30 | Irinotecan 14day | 2 | N | 270018313 | IRINOTECAN |
| 270014401 | 270010147 | 1.86 | 80.3 | Curative (C) | 2018-04-17 | 2018-04-18 | Bevacizumab | N | N | 270018317 | PANITUMUMAB |
| 270014402 | 270010149 | 1.69 | 55.7 | Curative (C) | 2015-07-25 | 2015-08-09 | Cetuximab + Oxaliplatin + MdG Load | N | N | 270018317 | BEAM + ALEMTUZUMAB |
| 270014403 | 270010151 | 1.5 | null | Adjuvant (A) | 2016-12-25 | 2016-12-28 | Irinotecan | N | N | 270018385 | IRINOTECAN |
| 270014404 | 270010153 | 1.74 | 102 | Adjuvant (A) | 2015-04-26 | 2015-05-03 | CETUXIMAB + OXALIPLATIN + MDG | 02 | N | 270018386 | VEPEMB |
| 270014405 | 270014743 | null | 88.2 | Curative (C) | 2013-05-25 | 2013-06-23 | Vinblastine | N | null | 270018394 | VEPEMB |
| 270014406 | 270010155 | 0 | 66 | Curative (C) | 2014-05-18 | 2015-01-11 | CETUXIMAB + OXALIPLATIN + MDG | N | N | 270018394 | CISPLATIN |
| 270014407 | 270010155 | null | 68.8 | Curative (C) | 2017-06-28 | 2017-07-07 | Bevacizumab 5mg/kg | N | N | 270018394 | CARBOPLATIN |
| 270014408 | 270010158 | 1.59 | 65 | Not known (9) | 2014-04-30 | 2014-05-19 | AFLIBERCEPT + FU + IRINOTECAN | 02 | N | 270018427 | IGEV |
| 270014409 | 270010158 | 1.85 | null | Curative (C) | 2015-03-20 | 2015-03-27 | GDP | N | Y | 270018427 | GDP |
| 270014410 | 270010160 | 1.83 | 85 | Curative (C) | 2016-09-09 | 2016-09-13 | GEM-P | N | null | 270018453 | GEMCITABINE + PACLITAXEL |
| 270014411 | 270010163 | 1.67 | 83.8 | null | 2013-02-18 | 2013-03-05 | VEPEMB | null | N | 270018453 | VEPEMB |
| 270014412 | 270010165 | 1.64 | 83.1 | Palliative (P) | 2013-10-07 | 2013-10-11 | AFLIBERCEPT + FU + IRINOTECAN | 2 | null | 270018473 | IGEV |
| 270014416 | 270014751 | 1.5 | 81 | Neo-adjuvant (N) | 2015-01-19 | 2015-02-08 | GEMCITABINE | N | N | 270018521 | CISPLATIN |
| 270014417 | 270010171 | 1.62 | 80.9 | Curative (C) | 2013-06-12 | 2013-07-03 | GDP | N | null | 270018542 | GDP |
| 270014418 | 270014753 | 1.85 | 80.3 | Palliative (P) | 2013-10-05 | 2013-10-07 | Bevacizumab 7.5mg/kg | 2 | N | 270018542 | CARBOPLATIN |
| 270014419 | 270010174 | 1.76 | 75 | Neo-adjuvant (N) | 2013-04-25 | 2013-04-25 | ABVD R | 02 | N | 270018591 | CISPLATIN |
| 270014420 | 270014755 | null | 36.8 | Palliative (P) | 2014-07-12 | 2014-07-12 | BEAM + Alemtuzumab Allo SCT | N | N | 270018597 | IGEV |
| 270014421 | 270010176 | 1.67 | 78 | Palliative (P) | 2015-06-22 | 2015-06-22 | Vinblastine | N | N | 270018606 | BEAM + ALEMTUZUMAB |
| 270014422 | 270010178 | null | 53 | Neo-adjuvant (N) | 2014-06-24 | 2014-08-06 | Panitumumab | N | N | 270018644 | ABVD R |
| 270014423 | 270010178 | 1.67 | 99.2 | Curative (C) | 2014-02-05 | 2014-09-13 | Vinblastine | N | N | 270018644 | CISPLATIN |
| 270014424 | 270010179 | null | null | Curative (C) | 2017-09-28 | 2017-10-03 | IVE | N | null | 270018671 | IVE |
| 270014425 | 270010179 | 1.72 | 66.6 | Palliative (P) | null | 2018-06-22 | Oxaliplatin + Raltitrexed | N | N | 270018671 | VINBLASTINE |
| 270014426 | 270010180 | 1.82 | 90 | Curative (C) | 2017-10-17 | 2017-12-24 | Cyclophosphamide High Dose | N | N | 270018702 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 270014427 | 270010181 | 1.64 | 72.9 | Adjuvant (A) | 2016-06-09 | 2016-06-09 | Vinblastine | N | null | 270018705 | IGEV |
| 270014428 | 270010182 | 1.52 | 66 | Neo-adjuvant (N) | 2015-02-13 | 2015-05-24 | Oxaliplatin + Raltitrexed | N | N | 270018705 | BEVACIZUMAB |
| 270014429 | 270014760 | 1.78 | 106.5 | Curative (C) | 2014-12-22 | 2014-12-26 | Vinblastine | 2 | N | 270018708 | AFLIBERCEPT + FU + IRINOTECAN |
| 270014430 | 270014760 | 1.62 | 42 | Curative (C) | 2014-06-09 | 2014-06-12 | BEAM + Alemtuzumab Allo SCT | N | N | 270018708 | IGEV |
| 270014431 | 270010186 | 1.78 | 106.5 | Curative (C) | 2015-05-01 | 2015-05-14 | AFLIBERCEPT + FU + IRINOTECAN | 2 | N | 270018715 | NIVOLUMAB |
| 270014432 | 270010187 | 1.76 | null | null | 2015-06-18 | 2015-06-24 | Panitumumab | N | N | 270018756 | CARBOPLATIN |
| 270014433 | 270014762 | 1.72 | 77.4 | Curative (C) | 2015-08-24 | 2016-10-04 | Cisplatin | 2 | N | 270018761 | IGEV |
| 270014434 | 270010189 | 1.8 | 85.2 | Curative (C) | 2015-03-29 | 2015-04-13 | Cetuximab + FLUOROURACIL + OXALIPLATIN | N | N | 270018776 | AFLIBERCEPT + FU + IRINOTECAN |
| 270014435 | 270010193 | 1.72 | 85 | Curative (C) | 2013-07-16 | 2013-07-16 | CISPLATIN + GEMCITABINE | N | Y | 270018778 | CISPLATIN |
| 270014436 | 270010194 | 1.86 | null | Neo-adjuvant (N) | 2016-02-03 | 2016-02-18 | GEMCITABINE + IFOSFAMIDE + VINORELBINE | N | N | 270018778 | VEPEMB |
| 270014437 | 270010196 | 1.67 | 87 | Palliative (P) | 2015-11-08 | 2015-11-08 | Bendamustine +/- Prednisolone | N | N | 270018795 | BENDAMUSTINE |
| 270014438 | 270010199 | null | 85 | Curative (C) | 2016-09-12 | 2016-09-12 | Bevacizumab | 02 | N | 270018827 | AFLIBERCEPT + FU + IRINOTECAN |
| 270014439 | 270014767 | 1.78 | 90.9 | Curative (C) | 2013-07-04 | 2013-08-01 | BEAM + Alemtuzumab Allo SCT | N | null | 270018829 | GEMCITABINE |
| 270014440 | 270010206 | 1.71 | 90.3 | Palliative (P) | 2013-09-11 | 2013-09-18 | Carboplatin AUC 2 - 5 | 2 | N | 270018831 | CISPLATIN + GEMCITABINE |
| 270014441 | 270010207 | 1.53 | 68 | Curative (C) | 2016-12-30 | 2017-01-06 | BEAM + Alemtuzumab Allo SCT | 2 | N | 270018834 | GEMCITABINE |
| 270014442 | 270010209 | 1.7 | 76.4 | Curative (C) | 2015-07-03 | 2015-09-13 | NIVOLUMAB | N | N | 270018840 | VINBLASTINE |
| 270014443 | 270010209 | null | 97.2 | Neo-adjuvant (N) | 2018-01-13 | 2018-01-18 | Cisplatin 7 day | 2 | N | 270018840 | CARBOPLATIN |
| 270014444 | 270010210 | 1.64 | 95.6 | Not known (9) | 2016-09-17 | 2016-10-01 | Panitumumab | N | N | 270018850 | PANITUMUMAB |
| 270014445 | 270010211 | 1.72 | null | Curative (C) | 2014-09-18 | 2014-09-26 | CISPLATIN + GEMCITABINE | 2 | N | 270018858 | BEVACIZUMAB |
| 270014446 | 270010211 | 1.77 | 60 | Curative (C) | 2016-06-11 | 2016-06-11 | Cisplatin+Gemcitabine (Days 1&8&15) | N | N | 270018858 | CISPLATIN + GEMCITABINE |
| 270014447 | 270010213 | 1.85 | 63 | Curative (C) | 2016-08-13 | 2016-10-09 | GEMCITABINE + IFOSFAMIDE + VINORELBINE | N | N | 270018869 | CISPLATIN |
| 270014448 | 270010215 | 1.36 | 69 | Curative (C) | 2017-02-18 | 2017-02-25 | Vinblastine | 02 | N | 270018871 | NIVOLUMAB |
| 270014449 | 270010216 | 1.54 | 47 | Disease modification (D) | 2016-01-12 | 2016-01-29 | GDP | 02 | N | 270018889 | GDP |
| 270014450 | 270010220 | 1.59 | 81.7 | Curative (C) | 2015-11-07 | 2015-11-07 | GDP | N | N | 270018894 | GDP |
| 270014454 | 270010224 | null | 69 | Curative (C) | 2017-09-29 | 2017-10-05 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | null | 270018973 | CISPLATIN |